Maintenance fees coming due
Vertex Pharmaceuticals Incorporated
66 maintenance fees come due in the 12 months from Nov 16, 2026, the next on Nov 19, 2026. Unpaid by May 19, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 9,035,053 | Processes for Making Compounds Useful as Inhibitors of ATR Kinase In force Fee due Nov 19, 2026 Lapses if unpaid May 19, 2027 · High confidence | Vertex Pharmaceuticals Incorporated | In force | Nov 19, 2026 | May 19, 2027 | High confidence | |
| US 9,035,072 | Process of Producing Cycloalkylcarboxamido-Indole Compounds In force Fee due Nov 19, 2026 Lapses if unpaid May 19, 2027 · High confidence | Vertex Pharmaceuticals Incorporated | In force | Nov 19, 2026 | May 19, 2027 | High confidence | |
| US 9,038,488 | Systems and Methods for Inline Sampling In force Fee due Nov 26, 2026 Lapses if unpaid May 26, 2027 · High confidence | Vertex Pharmaceuticals Incorporated | In force | Nov 26, 2026 | May 26, 2027 | High confidence | |
| US 10,301,304 | Selective Inhibitor of Phosphatidylinositol 3-Kinase-GAMMA In force Fee due Nov 28, 2026 Lapses if unpaid May 28, 2027 · High confidence | Vertex Pharmaceuticals Incorporated | In force | Nov 28, 2026 | May 28, 2027 | High confidence | |
| US 10,302,602 | Process of Conducting High Throughput Testing High Performance Liquid Chromatography In force Fee due Nov 28, 2026 Lapses if unpaid May 28, 2027 · High confidence | Vertex Pharmaceuticals Incorporated | In force | Nov 28, 2026 | May 28, 2027 | High confidence | |
| US 9,045,425 | Solid Forms of N-[2,4-BIS(1,1-Dimethylethyl)-5-Hydroxyphenyl]-1,4-Dihydro-4-Oxoquinoline-3-Carboxamide In force Fee due Dec 2, 2026 Lapses if unpaid Jun 2, 2027 · High confidence | Vertex Pharmaceuticals Incorporated | In force | Dec 2, 2026 | Jun 2, 2027 | High confidence | |
| US 9,051,270 | Pyridone Amides as Modulators of Sodium Channels In force Fee due Dec 9, 2026 Lapses if unpaid Jun 9, 2027 · High confidence | Vertex Pharmaceuticals Incorporated | In force | Dec 9, 2026 | Jun 9, 2027 | High confidence | |
| US 9,051,303 | Solid Forms of (R)-1(2,2-Difluorobenzo[D][1,3]DIOXOL-5-YL)-N-(1-(2,3-Dihydroxypropyl)-6-Fluoro-2-(1-Hydroxy-2-Methylpropan-2-YL)-1H-LNDOL-5-YL)CYCLOPROPANECARBOXAMIDE In force Fee due Dec 9, 2026 Lapses if unpaid Jun 9, 2027 · Medium confidence | Vertex Pharmaceuticals Incorporated | In force | Dec 9, 2026 | Jun 9, 2027 | Medium confidence | |
| US 9,051,319 | Inhibitors of Influenza Viruses Replication In force Fee due Dec 9, 2026 Lapses if unpaid Jun 9, 2027 · Medium confidence | Vertex Pharmaceuticals Incorporated | In force | Dec 9, 2026 | Jun 9, 2027 | Medium confidence | |
| US 9,051,324 | Modulators of Cystic Fibrosis Transmembrane Conductance Regulator In force Fee due Dec 9, 2026 Lapses if unpaid Jun 9, 2027 · Medium confidence | Vertex Pharmaceuticals Incorporated | In force | Dec 9, 2026 | Jun 9, 2027 | Medium confidence | |
| 56 more maintenance fees coming due in the 12 months from Nov 16, 2026 · Pro | |||||||
10 of 66 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.